pramipexole has been researched along with Movement Disorders in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 5 (62.50) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Doyu, M; Ibi, T; Niwa, J; Taguchi, S | 1 |
| Letvinenko, IV; Mogil'naia, VI; Odinak, MM | 1 |
| Cho, JY; Cho, YJ; Hong, KS; Jeon, BS; Kim, HJ; Lee, DH; Park, SY; Seo, SY | 1 |
| Alkhater, RA; Minassian, BA; Rilstone, JJ | 1 |
| Brecht, HM; Koester, J; Lemke, MR; Reichmann, H | 1 |
| Burghaus, L; Eggers, C; Fink, GR; Hilker, R; Liu, WC; Roggendorf, J; Weisenbach, S | 1 |
| Oertel, WH; Pinter, MM; Pogarell, O | 1 |
4 trial(s) available for pramipexole and Movement Disorders
| Article | Year |
|---|---|
[Pain and depression in Parkinson's disease: new therapeutic possibilities of pramipexole].
Topics: Aged; Amantadine; Benzothiazoles; Depressive Disorder, Major; Dopamine Agonists; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Movement Disorders; Pain; Pain Measurement; Parkinson Disease; Pramipexole; Severity of Illness Index | 2008 |
Long-term effect of initiating pramipexole vs levodopa in early Parkinson disease.
Topics: Aged; Antiparkinson Agents; Benzothiazoles; Cohort Studies; Disability Evaluation; Disease Progression; Early Diagnosis; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Movement Disorders; Outcome Assessment, Health Care; Parkinson Disease; Pramipexole; Quality of Life; Time; Treatment Outcome | 2009 |
Effects of the dopamine agonist pramipexole on depression, anhedonia and motor functioning in Parkinson's disease.
Topics: Aged; Benzothiazoles; Chi-Square Distribution; Depression; Dopamine Agonists; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Mood Disorders; Movement Disorders; Parkinson Disease; Pramipexole; Prospective Studies; Psychiatric Status Rating Scales; Severity of Illness Index | 2006 |
Efficacy, safety, and tolerance of the non-ergoline dopamine agonist pramipexole in the treatment of advanced Parkinson's disease: a double blind, placebo controlled, randomised, multicentre study.
Topics: Adult; Aged; Antiparkinson Agents; Benzothiazoles; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease; Pramipexole; Prospective Studies; Thiazoles | 1999 |
4 other study(ies) available for pramipexole and Movement Disorders
| Article | Year |
|---|---|
[Dyskinesia-hyperpyrexia syndrome in a patient with Parkinson's disease: a case report].
Topics: Aged; Benzothiazoles; Delayed-Action Preparations; Drug Substitution; Drug Therapy, Combination; Female; Fever; Humans; Levodopa; Movement Disorders; Parkinson Disease; Pramipexole; Selegiline | 2015 |
Nonmotor symptoms in de novo Parkinson disease before and after dopaminergic treatment.
Topics: Aged; Antiparkinson Agents; Benzothiazoles; Cognition Disorders; Comorbidity; Disability Evaluation; Dopamine Agonists; Female; Gastrointestinal Diseases; Humans; Indoles; Levodopa; Male; Memory Disorders; Middle Aged; Mood Disorders; Movement Disorders; Neurologic Examination; Nocturia; Outcome Assessment, Health Care; Parkinson Disease; Pramipexole; Prevalence; Restless Legs Syndrome; Treatment Outcome | 2009 |
Brain dopamine-serotonin vesicular transport disease and its treatment.
Topics: Age of Onset; Base Sequence; Benzothiazoles; Chromosomes, Human, Pair 10; Dopamine; Dopamine Agonists; Dopamine Plasma Membrane Transport Proteins; Dystonia; Female; Humans; Infant; Male; Molecular Sequence Data; Mood Disorders; Movement Disorders; Mutation; Parkinsonian Disorders; Pedigree; Pramipexole; Sequence Analysis, DNA; Serotonin; Serotonin Plasma Membrane Transport Proteins; Syndrome; Vesicular Monoamine Transport Proteins | 2013 |
Belly dancer's syndrome following central pontine and extrapontine myelinolysis.
Topics: Adult; Benzothiazoles; Brain; Dancing; Female; Humans; Hyponatremia; Magnetic Resonance Imaging; Movement Disorders; Myelinolysis, Central Pontine; Pons; Pramipexole; Restless Legs Syndrome | 2007 |